0.297
price down icon1.30%   -0.003
 
loading

Medicus Pharma Ltd Aktie (MDCX) Neueste Nachrichten

pulisher
May 23, 2026

MDCX Should I Buy - Intellectia AI

May 23, 2026
pulisher
May 22, 2026

Medicus Pharma Ltd (MDCX) Stock Price, Quote, News & History - Benzinga

May 22, 2026
pulisher
May 22, 2026

Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony - Chillicothe Gazette

May 22, 2026
pulisher
May 22, 2026

New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast (NASDAQ:CAST), Stardust Power (NASDAQ:SDST), Lost Soldier Oil and Gas, Virtuix Holdings (NASDAQ:VTIX), and Medi - ACCESS Newswire

May 22, 2026
pulisher
May 21, 2026

MDCX Stock Price, Quote & Chart | MEDICUS PHARMA LTD (NASDAQ:MDCX) - ChartMill

May 21, 2026
pulisher
May 20, 2026

MDCX Technical Analysis | Trend, Signals & Chart Patterns | MEDICUS PHARMA LTD (NASDAQ:MDCX) - ChartMill

May 20, 2026
pulisher
May 19, 2026

Medicus Pharma Ltd. (MDCXW) Reports FDA Progress and Expands 2026 Clinical Outlook - Insider Monkey

May 19, 2026
pulisher
May 16, 2026

User - The Chronicle-Journal

May 16, 2026
pulisher
May 15, 2026

Small cap wrap: Digi Power X, New Era Energy & Digital, 374Water, Medicus Pharma… - Proactive financial news

May 15, 2026
pulisher
May 15, 2026

Medicus Pharma (Nasdaq: MDCX) Advances Lead Skin Cancer Regimen - MyChesCo

May 15, 2026
pulisher
May 15, 2026

Medicus Pharma sees catalyst-rich year ahead as SkinJect and Teverelix progress - Yahoo Finance

May 15, 2026
pulisher
May 15, 2026

MSN Money - MSN

May 15, 2026
pulisher
May 15, 2026

MDCX Stock Chart | MEDICUS PHARMA LTD (NASDAQ:MDCX) - ChartMill

May 15, 2026
pulisher
May 14, 2026

Medicus Pharma 1Q Loss/Shr 31c >MDCX - Moomoo

May 14, 2026
pulisher
May 14, 2026

Medicus Pharma Ltd reports results for the quarter ended December 31Earnings Summary - TradingView

May 14, 2026
pulisher
May 14, 2026

Medicus Pharma (MDCX) registers 3.25M shares as warrants remain exercisable - Stock Titan

May 14, 2026
pulisher
May 14, 2026

Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times

May 14, 2026
pulisher
May 14, 2026

Medicus Pharma Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 14, 2026
pulisher
May 14, 2026

Medicus Pharma (NASDAQ: MDCX) flags going concern as Q1 loss widens - Stock Titan

May 14, 2026
pulisher
May 13, 2026

TradingKey - TradingKey

May 13, 2026
pulisher
May 10, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 10, 2026
pulisher
May 09, 2026

New to The Street Broadcasts Show #752 on Bloomberg Television Featuring Graphene Manufacturing Group (OTCQX:GMGRF), T-REX Acquisition Corp (NASDAQ:TRXA), KITON, and Roadzen (NASDAQ:RDZN) - Moomoo

May 09, 2026
pulisher
May 08, 2026

Medicus Pharma Ltd expected to post a loss of 19 cents a shareEarnings Preview - TradingView

May 08, 2026
pulisher
May 08, 2026

Maxim Group Maintains Medicus Pharma(MDCX.US) With Buy Rating, Maintains Target Price $2 - Moomoo

May 08, 2026
pulisher
May 08, 2026

Medicus Pharma Reports Expanded Phase 2 Skin Cancer Trial Data - MyChesCo

May 08, 2026
pulisher
May 07, 2026

EXCLUSIVE: Medicus Sees Strongest Efficacy At Higher Dose In Skin Cancer Study - Sahm

May 07, 2026
pulisher
May 06, 2026

Market movers: Uber, Super Micro Computer, Medicus Pharma, Arizona Gold & Silver, Hut 8... - Proactive financial news

May 06, 2026
pulisher
May 06, 2026

Medicus Pharma reports strong Phase 2 dose response in skin cancer study - Proactive financial news

May 06, 2026
pulisher
May 06, 2026

Medicus Pharma reports dose response data from skin cancer study By Investing.com - Investing.com India

May 06, 2026
pulisher
May 06, 2026

Medicus Pharma reports dose response data from skin cancer study - Investing.com UK

May 06, 2026
pulisher
May 06, 2026

Medicus Pharma highlights positive dose-response in updated skin cancer trial results - Yahoo Finance

May 06, 2026
pulisher
May 06, 2026

$Medicus Pharma (MDCX.US)$ - Moomoo

May 06, 2026
pulisher
May 06, 2026

Skin cancer study points to higher-dose winner with 55% response - Stock Titan

May 06, 2026
pulisher
May 06, 2026

Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response - ChartMill

May 06, 2026
pulisher
May 05, 2026

Ajay Raju and Togo PHL entities report 2.03M shares in Medicus Pharma (MDCX) - Stock Titan

May 05, 2026
pulisher
May 04, 2026

Medicus Pharma Meets Lawmakers to Advance SkinJect Program - MyChesCo

May 04, 2026
pulisher
May 04, 2026

[ARS] Medicus Pharma Ltd. SEC Filing - Stock Titan

May 04, 2026
pulisher
May 03, 2026

Medicus reports Phase 2 basal cell carcinoma trial results By Investing.com - Investing.com India

May 03, 2026
pulisher
May 01, 2026

Medicus Pharma (MDCX) plans up to 50-for-1 share consolidation to address Nasdaq bid-price rule - Stock Titan

May 01, 2026
pulisher
Apr 30, 2026

MDCX SEC FilingsMedicus Pharma Ltd 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

Medicus Pharma on Bloomberg World - Public Opinion

Apr 30, 2026
pulisher
Apr 30, 2026

Medicus Pharma 2025 Executive Compensation, Board Governance, and Equity Incentive Plan Overview - Minichart

Apr 30, 2026
pulisher
Apr 29, 2026

Medicus Pharma (Nasdaq: MDCX) details board structure and leadership pay - Stock Titan

Apr 29, 2026
pulisher
Apr 29, 2026

Exclusive: Medicus Pharma refines trial design to cut costs, accelerate development for enlarged prostate patients - MSN

Apr 29, 2026
pulisher
Apr 29, 2026

10-K/A: Annual report (Amendment) - Moomoo

Apr 29, 2026
pulisher
Apr 27, 2026

MDCXW Price History for Medicus Pharma Ltd WT Stock - Barchart.com

Apr 27, 2026
pulisher
Apr 27, 2026

Medicus Pharma lobbies Congress on SkinJect regulatory pathway for rare Gorlin syndrome - Yahoo! Finance Canada

Apr 27, 2026
pulisher
Apr 27, 2026

Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill - The Manila Times

Apr 27, 2026
PFE PFE
$25.88
price down icon 0.23%
$135.72
price up icon 4.05%
$341.67
price up icon 1.35%
NVO NVO
$44.81
price down icon 0.98%
NVS NVS
$151.98
price down icon 0.18%
AZN AZN
$188.15
price down icon 0.77%
Kapitalisierung:     |  Volumen (24h):